Flexus Biosciences Alternatives & Competitors
12 companies similar to Flexus Biosciences — Bristol-Myers Squibb acquired Flexus for $800M upfront & $450M in potential earn...
Companies similar to Flexus Biosciences
Anchiano Therapeutics
Dedicated to the discovery, development, and commercialization of novel targeted therapies...
Xanthus Pharmaceuticals
Innovative treatments for cancer and autoimmune disorders through pioneering small-molecul...
Genus Oncology LLC
Discovering New Frontiers in Anti-Cancer Therapeutics: Targeting MUC1 for a Healthier Tomo...
Coherus BioSciences
We are in the business of extending life for patients.
Rival Readout
Competing with Flexus Biosciences? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
NEOGAP Therapeutics AB
Science for cure.
TRACON Pharmaceuticals
Our Goal is to be the Leader in the Development of Targeted Therapies for Patients with Ca...
Biond Biologics Ltd
Biond - Innovative immunotherapies and a pioneering intracellular delivery for biologics f...
Focal Medical, Inc. (acquired by Continuity Biosciences)
We are developing novel targeted therapeutic products based on our innovative local drug-d...
Novira Therapeutics
Discovering & developing novel antivirals. Novira was founded by Dr. Ali H. Munawar in 200...
Soricimed Biopharma Inc.
Dedicated to developing effective and novel targeted treatments for cancer.
Forma Therapeutics
Dedicated to transforming the lives of patients with rare hematologic diseases and cancers...
About Flexus Biosciences
Flexus Biosciences, a biopharmaceutical startup founded in 2013, drew significant attention in 2015 when it was acquired by Bristol-Myers Squibb for a substantial amount of $800M upfront and $450M in potential earnouts. The company focuses on developing and commercializing novel anti-cancer therapeutics using unexploit...
Biopharmaceutical, Cancer Therapeutics, Immunology, Oncology Research, Drug Development, Discovery Research, Biotech, Pharmaceutical, Innovation, Biomedical, Cancer Treatment, Therapeutic Development
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Flexus Biosciences: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Flexus Biosciences on 12 Sep 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.